Compare MVST & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MVST | SENS |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
| Sector | Miscellaneous | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.7M | 301.2M |
| IPO Year | 2019 | 2014 |
| Metric | MVST | SENS |
|---|---|---|
| Price | $0.83 | $7.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $18.38 |
| AVG Volume (30 Days) | ★ 6.1M | 638.7K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.25 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $427,516,000.00 | $16,389,000.00 |
| Revenue This Year | $24.55 | $74.15 |
| Revenue Next Year | $17.08 | $58.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 12.56 | ★ 19.85 |
| 52 Week Low | $0.71 | $0.41 |
| 52 Week High | $7.12 | $8.75 |
| Indicator | MVST | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 75.96 |
| Support Level | $0.71 | $7.35 |
| Resistance Level | $1.38 | $8.49 |
| Average True Range (ATR) | 0.09 | 0.47 |
| MACD | 0.02 | 0.34 |
| Stochastic Oscillator | 35.87 | 80.16 |
Microvast Holdings Inc develops lithium-ion battery technologies focused on high-performance solutions for commercial and industrial electrification. The Company designs, develops, and manufactures battery components and systems for electric commercial vehicles and energy storage systems (ESS), with applications across buses, trucks, port equipment, and mining machinery. It emphasizes innovation in battery design without relying on legacy technologies and supports platforms such as the IVECO eDaily and various bus models. The Company also provides services, repairs, and warranty and extended warranty support. It operates as a single reportable segment, covering design, development, manufacturing, sales, and leasing of battery systems, and generates the majority of its revenue from Europe.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.